跳至主要内容
临床试验/NCT02436538
NCT02436538已完成不适用

Correlation Between Serum Anti-Müllerian Hormone (AMH) Levels & Müllerian Ducts Anomalies in Patients Undergoingintracytoplasmic Sperm Injection (ICSI)

Ahmed M.Kamel1 个研究点 分布在 1 个国家目标入组 226 人开始时间: 2015年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
226
试验地点
1
主要终点
Correlation of serum anti-Müllerian hormone (AMH) level with mullerian anomalies

研究概览

简要总结

Anti-Müllerian hormone (AMH), also known as Müllerian inhibiting substance, is a dimeric glycoprotein that belongs to the transforming growth factor-beta family. It is involved in the regression of the Müllerian ducts during male fetal development. In the female, AMH is solely produced by the granulosa cells of preantral and small antral follicles, and regulates ovarian activity and follicular steroidogenesis

详细描述

Following approval of the internal review board of Egyptian IVF-ET center, a retrospective analysis will be undertaken where a detailed review of the patients files who underwent intracytoplasmic sperm injection (ICSI) trials starting January 2010 till January 2015 will be done.

Patients with diagnosed mullerian anomalies will have their name , age ,duration of infertility, serum FSH, LH ,& AMH levels recorded. The method of diagnosis (HSG, 3D/ultrasonography, hysteroscopy, or laparoscopy) will also be documented.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • women with diagnosed mullerian anomlies whether clinically or through imaging

排除标准

  • previous ovarian surgery
  • ovarian drilling
  • polycystic ovarian syndrome (PCOs).

结局指标

主要结局

Correlation of serum anti-Müllerian hormone (AMH) level with mullerian anomalies

时间窗: 2 years

次要结局

未报告次要终点

研究者

发起方
Ahmed M.Kamel
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ahmed M.Kamel

lecturer Of obstetrics & Gynecology

Kasr El Aini Hospital

研究点 (1)

Loading locations...

相似试验

Correlation Between Serum Anti-Müllerian Hormone &... | 临床试验